The contemporary landscape of healthcare delivery has undergone a seismic shift, notably with the advent of the COVID-19 pandemic that catalysed the widespread adoption of remote consultations. This transformation has sparked a pivotal discussion: is remote or face-to-face care the optimal approach for managing acute cystitis? A recent study published in the BJGP Open delves into this inquiry, offering critical insights into how these two consultation methods compare in terms of antibiotic treatment and clinical outcomes.
Remote Consultations: A Rising Trend
The research, conducted by Lars Emil Aga Haugom and colleagues from the University of Bergen, scrutinised data from a four-year period (2018-2021) in Norway. During this time, the prevalence of remote consultations for acute cystitis surged significantly, from a modest 0.5% in 2018 to a remarkable 15.2% by 2021. This increase underscores the growing reliance on technology to bridge the gap between patients and healthcare providers amidst the pandemic-induced constraints.
Antibiotic Treatment Patterns
One of the study's focal points was the comparison of antibiotic treatments following remote and in-person consultations. It was observed that remote consultations were associated with a higher likelihood of prescribing second-line antibiotics. Specifically, the adjusted relative risk (aRR) for second-line antibiotic treatment was 1.05, with a confidence interval of 95% (CI 1.03–1.07), a significant finding with a p-value of less than 0.001.
Repeat Contacts and Clinical Outcomes
The study also highlighted differences in clinical outcomes, as evidenced by the frequency of repeat contacts within 14 days post-consultation. Here again, remote consultations led to more repeat visits, with an aRR of 1.11 (95% CI, 1.09-1.13, P<0.001). These findings suggest that while remote consultations offer convenience, they may also necessitate further follow-ups, potentially indicating unresolved or recurrent symptoms.
Interpreting the Findings
The unique context of the COVID-19 pandemic and the structured general practitioner scheme in Norwegian primary care are crucial factors to consider when interpreting these results. The shift towards remote consultations was, in part, a necessary adaptation to maintain patient care amid social distancing mandates. However, this study raises essential questions about the implications of such shifts on treatment efficacy and patient outcomes.
Conclusion: Navigating the Future of Care
As healthcare systems worldwide continue to evolve in the post-pandemic era, the insights from this study are invaluable. They prompt a re-evaluation of how remote consultations can be optimised to ensure they are not only convenient but also effective. Balancing technological integration with traditional face-to-face interactions might be key to enhancing overall patient care for conditions like acute cystitis.
The findings urge healthcare providers and policymakers to consider both the benefits and challenges of remote consultations, striving for an approach that harnesses the best of both worlds. As we navigate the future of healthcare delivery, embracing innovation while maintaining a patient-centred focus will be paramount.
Source: Remote vs. in-person consultations for acute cystitis: antibiotic treatment and clinical outcomes,